Oxford Bioscience Boss, 59, Faces Fraud Allegations Over Company Funds
Senior executive accused of diverting money from pioneering biotech firm A 59-year-old boss of an Oxford-based bioscience company has been accused of pocketing company funds in a case that raises fresh questions about accountability in the fast-moving world of regenerative medicine. The executive, who cannot be named here until trial confirmation, allegedly diverted thousands of pounds from the company’s accounts into personal or undisclosed channels. Prosecutors claim the transfers breached his fiduciary duty and were carried out without proper authorisation. Court proceedings The case was heard at Oxford Crown Court , where the accused entered a not guilty plea to charges of fraud and misappropriation. The prosecution alleges that company accounts were used to cover personal expenses and unapproved payments, leaving investors and colleagues in the dark. The defense maintains the transactions were legitimate business expenses, tied to consultancy ar...